InvestorsHub Logo
Followers 2543
Posts 250731
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Monday, 09/15/2014 10:13:47 PM

Monday, September 15, 2014 10:13:47 PM

Post# of 158400
"We are grateful for the examiners at the FDA to have taken the time to walk us through their thinking and explaining to us what they believe will add the greatest level of safety to our HemaXellerate product. By closely working with the FDA now, we believe the path for future trials, including other disease indications will be much smoother," said Thomas Ichim, PhD, Chief Scientific Officer of Regen BioPharma Inc.

$BMSN

Pistol Pete!

"Patience, persistence and perspiration make an unbeatable combination for success."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.